New facilities, hires and studies advance ingredient market
Kerry open coffee extraction facility

Kerry officially opened its state-of-the-art coffee extraction facility in Bethlehem, Pa., the company’s first manufacturing site in the state. Kerry marked the opening on Sept. 30 with a ribbon-cutting ceremony that brought together customers, industry partners, government representatives, and community leaders for guided facility tours and product tastings. With plans first announced in September 2025, the site is dedicated to developing natural coffee taste and flavor profiles using advanced extraction and concentration technologies to create premium coffee solutions tailored to each customer’s formulation, from ready-to-drink (RTD) coffee beverages to alcoholic drinks, ice cream and savory sauces. The facility increases Kerry’s overall coffee extraction capabilities significantly, with independent hot and cold brew extraction lines designed to scale as demand grows, the company says.
California Natural Color, a global ingredient supplier of natural colors, premium grape juice concentrates and grape seed extract, announced Amy Rapier has joined the company as quality director. In this role, Rapier will oversee product evaluation, sourcing and innovation to ensure quality across all stages of development and manufacturing. “We are thrilled to welcome Amy Rapier to the California Natural Color team,” said Dana Osborn, marketing manager at California Natural Color, in a statement. “Amy is an authority in the quality control field with nearly two decades of experience implementing safety measures in both food and packaging.” As quality director, Rapier will develop, manage and implement food safety standards across ingredient sourcing, new product development, regulatory, compliance and quality services, the company says.
A clinical trial has validated the fast-acting cognitive and mood benefits of Nektium’s water-soluble Zynamite mango leaf extract, a non-stimulant caffeine alternative that does not produce side effects such as jitters, crashes or sleeplessness. Clinical tests carried out in 2025 showed that a single 100 mg dose delivers sustained mental focus and emotional balance. A new study, published in Pharmaceuticals, was created to replicate and validate those findings. The results reproduced the acute benefits in a healthy young adult population, including a rapid onset of effects and a sustained improvement in cognitive performance and mood over a five-hour window, the company says.
Looking for a reprint of this article?
From high-res PDFs to custom plaques, order your copy today!


